Eugene

[email protected]

LATEST

Mylan Allowed to Proceed with Patent Challenge Against Allergan for Blockbuster Drug Restasis
By

By
Mylan has received a favorable ruling from the US Patent Trial and Appeal Board (PTAB), which denied a motion by the St. Regis Mohawk Tribe to terminate Mylan’s patent challenge…

Pfizer’s Hospira Voluntarily Recalls Three Lots of Labetalol HCl Over Cracked Vials
By

By
Hospira, a Pfizer company, is voluntarily recalling three lots of labetalol hydrochloride injection (100 mg/20 mL), a blood-pressure drug, and one lot of labetalol hydrochloride injection (Novaplus) to the hospital/institution…

Pall Supplies Products for Bioprocessing Training Center in Singapore
By

By
Pall Corporation, a provider of filtration, separation, and purification products and services, is providing products for a $2-million center of excellence for biologics manufacturing for Nanyang Polytechnic, a training institute…

West Pharmaceutical Services To Streamline Manufacturing Plant Network
By

By
West Pharmaceutical Services, a manufacturer of packaging and delivery systems for injectable drugs and healthcare products, has approved a restructuring program to streamline its manufacturing plant network. The restructuring is…

Catalent, Biohaven in Fast-Dissolving Oral Solid-Dose Supply Pact
By

By
Catalent has formed an agreement with Biohaven Pharmaceutical Holding Company, the parent company of Biohaven Pharmaceuticals, a clinical-stage biopharmaceutical company, to provide Catalent’s Zydis orally disintegrating tablet (ODT) technology for…

Dyadic Partners for its Fungus-Based Expression System
By

By
Dyadic International, a Jupiter, Florida-based biopharmaceutical company, has entered into a proof-of-concept research collaboration with an unnamed biotechnology company to use its proprietary C1 gene-expression platform technology to produce an…

Samsung BioLogics Signs Contract Worth up to $148-Million for New Mfg Facility in Korea
By

By
Samsung BioLogics, an Incheon, Korea-based contract biologics manufacturer, has entered into its first manufacturing contract for its newest biologics manufacturing facility in Songdo, South Korea. The approximate value of the…

AstraZeneca, Bavarian Nordic Partner in Cancer Pact
By

By
AstraZeneca has partnered with Bavarian Nordic, a Kvistgaard, Denmark-based biopharmaceutical company, to investigate Bavarian’s targeted immunotherapy candidate, CV301, and durvalumab, AstraZeneca’s programmed death ligand-1 (PD-L1) inhibitor, in combination with maintenance…

Ferring Pharma To Invest $31 Million in New Biotech Center
By

By
Ferring Pharmaceuticals, a biopharmaceutical company globally headquartered in Switzerland, plans to invest CHF 30 million ($31 million) in a new biotechnology center at the company’s existing global headquarters and manufacturing…

Fujifilm To Invest $37 Million in New Liposomal Mfg Facility
By

By
Fujifilm plans to invest approximately 4 billion yen ($37 million) in a pharmaceutical production site of its group company, Toyama Chemical Co., to build a new manufacturing facility for liposome…